Energia Pharma Services
ActiveSummary
Energia Pharma Services has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €4.67M and a net result of €-115k. Equity is growing by ~47.1% per year across the filed fiscal years. Its solvency ranks better than 23% of 5989 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2024
43
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability29▼-8
Solvency44▼-1
Growth68▼-17
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €200k at 30 days only on tighter terms
Liquidity tight (current ratio 1.24 against 1.25 in 2023; short-term debt: 78.4% and cash: 1.7% of total assets), and 80.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
19.2%
Return on assets
-0.5%
Age of the figures
21 mo
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 5989 sector peers (2024).
NBB · sector comparisonPosition among 5989 sector peers
Solvency
better than 23%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 13-06-2025, 48 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
not confirmed
2024
48 d early
2023
47 d early
2022
52 d early
2021
46 d early
2020
46 d early
2019
49 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, full schema
Turnover
€33.50M▼ 14.3%
2023 · €39.08M
2019: €4.03M
2020: €2.98M
2021: €4.89M
2022: €36.37M
2023: €39.08M
2019 → 2024
EBIT margin
0.8%▼ 0.7pp
2023 · 1.5%
2019: 4.1%
2020: 1.6%
2021: 1.7%
2022: 1.9%
2023: 1.5%
2019 → 2024
Net result
€-115k
2023 · €171k
2019: €86k
2020: €14k
2021: €8k
2022: €442k
2023: €171k
2019 → 2024
Working capital
€4.58M▼ 0.9%
2023 · €4.62M
2019: €126k
2020: €139k
2021: €215k
2022: €4.53M
2023: €4.62M
2019 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Turnover€2.98M-€4.89M▲ 63.9%€36.37M▲ 644%€39.08M▲ 7.5%€33.50M▼ 14.3%
Equity€161k-€170k▲ 5.1%€4.61M▲ 2,617%€4.78M▲ 3.7%€4.67M▼ 2.4%
Operating result€47k-€81k▲ 71.1%€685k▲ 750%€569k▼ 17.0%€254k▼ 55.3%
Net result€14k-€8k▼ 41.7%€442k▲ 5,241%€171k▼ 61.3%€-115k
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 55% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €24.36M
Fixed assets
€680k ▼ 3.8%
Current assets
€23.68M ▲ 4.0%
Equity and liabilities €24.36M
Equity
€4.67M ▼ 2.4%
Debt
€19.69M ▲ 5.3%
Debt's share of the balance-sheet total rises from 79.6% to 80.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€371k▼
2023 · €634k
Cash flow
€2k▼
2023 · €237k
Current ratio
1.24▼
2023 · 1.25
Quick ratio
0.62▲
2023 · 0.53
Debt to equity
4.22▲
2023 · 3.91
ROE
-2.5%▼
2023 · 3.6%
ROA
-0.5%▼
2023 · 0.7%
Interest coverage
1.50▼
2023 · 2.80
Debt ≤ 1 year
€19.10M▲
2023 · €18.15M
Debt > 1 year
€526k▼
2023 · €535k
Income taxes
€1k▼
2023 · €90k
Staff costs
€1.28M▲
2023 · €1.15M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 80 lines
Balance sheet
Code20232024
Assets
Total assets20/58€23.48M€24.36M▲
Fixed assets21/28€707k€680k▼
Intangible fixed assets21€235k€242k▲
Tangible fixed assets22/27€323k€253k▼
Plant, machinery and equipment23€18k€28k▲
Furniture and vehicles24€273k€225k▼
Assets under construction and advance payments27€31k-
Financial fixed assets28€149k€185k▲
Affiliated companies280/1€78k€114k▲
Participating interests280€78k€114k▲
Other financial fixed assets284/8€71k€71k▲
Amounts receivable and cash guarantees285/8€71k€71k▲
Current assets29/58€22.77M€23.68M▲
Amounts receivable after more than one year29€609k€441k▼
Other amounts receivable291€609k€441k▼
Stocks and contracts in progress3€13.13M€11.80M▼
Stocks30/36€13.13M€11.80M▼
Goods purchased for resale34€13.13M€11.80M▼
Amounts receivable within one year40/41€8.79M€10.60M▲
Trade receivables40€8.51M€9.22M▲
Other amounts receivable41€273k€1.38M▲
Cash at bank and in hand54/58€666€411k▲
Deferred charges and accrued income490/1€247k€415k▲
Equity and liabilities
Total equity and liabilities10/49€23.48M€24.36M▲
Equity10/15€4.78M€4.67M▼
Contributions10/11€4.06M€4.06M=
Capital10€4.06M€4.06M=
Issued capital100€4.06M€4.06M=
Reserves13€37k€37k=
Non-distributable reserves130/1€37k€37k=
Legal reserve130€37k€37k=
Profit (loss) carried forward14€685k€571k▼
Amounts payable17/49€18.70M€19.69M▲
Amounts payable after more than one year17€535k€526k▼
Financial debts170/4€535k€526k▼
Credit institutions173€535k€526k▼
Amounts payable within one year42/48€18.15M€19.10M▲
Current portion of amounts payable after more than one year42€171k€221k▲
Financial debts43€6.37M€6.76M▲
Credit institutions430/8€6.37M€3.00M▼
Other loans439-€3.76M
Trade debts44€11.17M€11.86M▲
Suppliers440/4€11.17M€11.86M▲
Taxes, remuneration and social security45€451k€255k▼
Taxes450/3€271k€53k▼
Remuneration and social security454/9€180k€202k▲
Accrued charges and deferred income492/3€8k€64k▲
Income statement
Code20232024
Operating income70/76A€41.06M€35.52M▼
Turnover70€39.08M€33.50M▼
Other operating income74€1.98M€2.01M▲
Non-recurring operating income76A-€7k
Operating charges60/66A€40.49M€35.27M▼
Goods for resale, raw materials and consumables60€29.92M€30.69M▲
Purchases600/8€32.75M€29.36M▼
Change in stocks: decrease (increase)609€-2.83M€1.33M▲
Services and other goods61€9.28M€3.17M▼
Remuneration, social security and pensions62€1.15M€1.28M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€66k€117k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€39k-
Other operating charges640/8€4k€6k▲
Non-recurring operating charges66A€37k€4k▼
Operating profit (loss)9901€569k€254k▼
Financial income75/76B€18k€48k▲
Recurring financial income75€18k€48k▲
Income from financial fixed assets750€18k€19k▲
Other financial income752/9-€29k
Financial charges65/66B€326k€415k▲
Recurring financial charges65€326k€415k▲
Debt charges650€227k€248k▲
Other financial charges652/9€99k€168k▲
Profit (loss) for the period before taxes9903€261k€-113k▼
Income taxes67/77€90k€1k▼
Taxes670/3€90k€1k▼
Profit (loss) for the period9904€171k€-115k▼
Profit (loss) for the period to be appropriated9905€171k€-115k▼
Appropriation of the result
Profit (loss) to be appropriated9906€694k€571k▼
Profit (loss) brought forward from the previous period14P€522k€685k▲
Transfer to equity691/2€9k-
To the legal reserve6920€9k-
Social balance
Average headcount (FTE)908717.717.4▼
The notes to these accounts (56 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet €-115k ▼167%
Net result drops to €-115k, the lowest in the series.
14-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
09-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Highest result since 2019net €442k ▲5241%
Operating result €685k, net result €442k, both a record.
31-12
Financial
Equity above €2MEq €4.61M ▲2617%
4 profitable years in a row build equity to €4.61M.
15-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
15-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Equity above €150kEq €161k ▲9.7%
2 profitable years in a row build equity to €161k.
12-06
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Turnhout · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Slachthuisstraat 302300 TurnhoutGround area
1.5 ha
Building footprint
2,945 m²
Volume, LiDAR
17,652 m³
Parcel 13453O0904/00G009, Flanders · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Energia Pharma Services
since 20182.271.891.735
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13453O0904/00G009 | Flanders | 1.5 ha | 1 · 2,944 m² | 9.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2024 to 2025 · 2 entries · 1,021 EUR awarded · 976 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 661 EUR | 616 EUR |
| 2024 | 1 | 360 EUR | 360 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Legal Entity Identifier
69940093WNALUKL5WW90
Similar companies · same sector, comparable size
ANDOCOR
BE 0458.952.035
Hoogstraten · Eq €4.69M
EISAI
BE 0891.958.055
Leuven · Eq €4.61M
EMDOKA
BE 0447.804.458
Hoogstraten · Eq €4.73M
SEBIA BENELUX
BE 0456.702.823
Vilvoorde · Eq €4.57M
GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline
BE 0403.066.474
Wavre · Eq €4.78M
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 579 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded10-01-2018
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
73200Market research and public opinion polling
47279Other retail sale of food
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
73110Advertising agencies
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.